François Jérôme Authier Selected Research

Immunoglobulin Light-chain Amyloidosis

1/2023

Systemic light chain amyloidosis myopathy responsive to daratumumab monotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

François Jérôme Authier Research Topics

Disease

7	Muscular Diseases (Myopathy) 01/2023 - 10/2014
3	Macrophagic myofasciitis 10/2018 - 01/2014
2	Dermatomyositis (Dermatopolymyositis) 01/2019 - 10/2014
1	Immunoglobulin Light-chain Amyloidosis 01/2023
1	Amyloidosis 01/2023
1	Arthrogryposis 01/2023
1	Paraproteinemias (Monoclonal Gammopathy) 01/2023
1	Muscle Weakness 01/2023
1	Amyloid Plaque 01/2023
1	Muscle Hypotonia (Hypotonia) 01/2021
1	Central Core Myopathy (Central Core Disease) 01/2021
1	Congenital Structural Myopathies (Centronuclear Myopathy) 01/2021
1	Malignant Hyperthermia 01/2021
1	Distal Myopathy with Anterior Tibial Onset 08/2020
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2020
1	Arthritis (Polyarthritis) 01/2020
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2020
1	Limb-girdle muscular dystrophy type 2A 12/2019
1	Cognitive Dysfunction 01/2018

Drug/Important Bio-Agent (IBA)

3	Aluminum Hydroxide (Algeldrate)FDA Link 10/2018 - 01/2014
2	InterferonsIBA 01/2020 - 01/2019
2	Ligases (Synthetase)IBA 01/2019 - 10/2014
1	ConnectinIBA 01/2023
1	daratumumabIBA 01/2023
1	Amyloid (Amyloid Fibrils)IBA 01/2023
1	Immunoglobulin A (IgA)IBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2021
1	DysferlinIBA 08/2020
1	AutoantibodiesIBA 01/2020
1	EnzymesIBA 12/2019
1	Histocompatibility Antigens Class IIIBA 10/2014
1	Biomarkers (Surrogate Marker)IBA 10/2014
1	HLA-DR Antigens (HLA-DR)IBA 10/2014

Therapy/Procedure

1	Therapeutics 01/2023